UK Advances Probe Of Elanco's Sale Of Dog Ear Treatment
The U.K.'s competition watchdog has formally opened the first phase of an investigation into Elanco Animal Health Inc.'s $135 million sale of a dog ear infection treatment to Dechra Pharmaceuticals that...To view the full article, register now.
Already a subscriber? Click here to view full article